These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 15461580)
1. Oncolytic measles viruses for cancer therapy. Nakamura T; Russell SJ Expert Opin Biol Ther; 2004 Oct; 4(10):1685-92. PubMed ID: 15461580 [TBL] [Abstract][Full Text] [Related]
2. Engineered measles virus as a novel oncolytic therapy against prostate cancer. Msaouel P; Iankov ID; Allen C; Morris JC; von Messling V; Cattaneo R; Koutsilieris M; Russell SJ; Galanis E Prostate; 2009 Jan; 69(1):82-91. PubMed ID: 18973133 [TBL] [Abstract][Full Text] [Related]
3. Measles virus selectively blind to signaling lymphocyte activation molecule as a novel oncolytic virus for breast cancer treatment. Sugiyama T; Yoneda M; Kuraishi T; Hattori S; Inoue Y; Sato H; Kai C Gene Ther; 2013 Mar; 20(3):338-47. PubMed ID: 22717740 [TBL] [Abstract][Full Text] [Related]
4. Engineered measles virus as a novel oncolytic viral therapy system for hepatocellular carcinoma. Blechacz B; Splinter PL; Greiner S; Myers R; Peng KW; Federspiel MJ; Russell SJ; LaRusso NF Hepatology; 2006 Dec; 44(6):1465-77. PubMed ID: 17133484 [TBL] [Abstract][Full Text] [Related]
5. Measles virus as an oncolytic vector platform. Blechacz B; Russell SJ Curr Gene Ther; 2008 Jun; 8(3):162-75. PubMed ID: 18537591 [TBL] [Abstract][Full Text] [Related]
6. [Synergistic Effect of NF-κB Signaling Pathway Inhibitor and Oncolytic Measles Virus Vaccine Strain against Lung Cancer and Underlying Mechanisms]. Xia M; Meng G; Dong J Zhongguo Fei Ai Za Zhi; 2021 Apr; 24(4):245-253. PubMed ID: 33775041 [TBL] [Abstract][Full Text] [Related]
7. Biosafety considerations for attenuated measles virus vectors used in virotherapy and vaccination. Baldo A; Galanis E; Tangy F; Herman P Hum Vaccin Immunother; 2016 May; 12(5):1102-16. PubMed ID: 26631840 [TBL] [Abstract][Full Text] [Related]
8. Measles virus induces oncolysis of mesothelioma cells and allows dendritic cells to cross-prime tumor-specific CD8 response. Gauvrit A; Brandler S; Sapede-Peroz C; Boisgerault N; Tangy F; Gregoire M Cancer Res; 2008 Jun; 68(12):4882-92. PubMed ID: 18559536 [TBL] [Abstract][Full Text] [Related]
10. Graphene oxide arms oncolytic measles virus for improved effectiveness of cancer therapy. Xia M; Luo D; Dong J; Zheng M; Meng G; Wu J; Wei J J Exp Clin Cancer Res; 2019 Sep; 38(1):408. PubMed ID: 31533779 [TBL] [Abstract][Full Text] [Related]
11. Intraperitoneal therapy of ovarian cancer using an engineered measles virus. Peng KW; TenEyck CJ; Galanis E; Kalli KR; Hartmann LC; Russell SJ Cancer Res; 2002 Aug; 62(16):4656-62. PubMed ID: 12183422 [TBL] [Abstract][Full Text] [Related]
12. Measles to the Rescue: A Review of Oncolytic Measles Virus. Aref S; Bailey K; Fielding A Viruses; 2016 Oct; 8(10):. PubMed ID: 27782084 [TBL] [Abstract][Full Text] [Related]
13. Wild-type measles virus infection in human CD46/CD150-transgenic mice: CD11c-positive dendritic cells establish systemic viral infection. Shingai M; Inoue N; Okuno T; Okabe M; Akazawa T; Miyamoto Y; Ayata M; Honda K; Kurita-Taniguchi M; Matsumoto M; Ogura H; Taniguchi T; Seya T J Immunol; 2005 Sep; 175(5):3252-61. PubMed ID: 16116216 [TBL] [Abstract][Full Text] [Related]
14. Attenuated oncolytic measles virus strains as cancer therapeutics. Msaouel P; Iankov ID; Dispenzieri A; Galanis E Curr Pharm Biotechnol; 2012 Jul; 13(9):1732-41. PubMed ID: 21740361 [TBL] [Abstract][Full Text] [Related]
15. Engineered measles virus Edmonston strain used as a novel oncolytic viral system against human hepatoblastoma. Zhang SC; Wang WL; Cai WS; Jiang KL; Yuan ZW BMC Cancer; 2012 Sep; 12():427. PubMed ID: 23009685 [TBL] [Abstract][Full Text] [Related]
16. Sensitivity of human pleural mesothelioma to oncolytic measles virus depends on defects of the type I interferon response. Achard C; Boisgerault N; Delaunay T; Roulois D; Nedellec S; Royer PJ; Pain M; Combredet C; Mesel-Lemoine M; Cellerin L; Magnan A; Tangy F; Grégoire M; Fonteneau JF Oncotarget; 2015 Dec; 6(42):44892-904. PubMed ID: 26539644 [TBL] [Abstract][Full Text] [Related]